Page last updated: 2024-12-05

4,4'-biphenyldicarboxylic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4,4'-biphenyldicarboxylic acid: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID13084
CHEMBL ID3593502
SCHEMBL ID69873
MeSH IDM0529718

Synonyms (59)

Synonym
biphenyl-4,4'-dicarboxylic acid
einecs 212-328-3
brn 0523308
nsc 60016
4,4'-biphenyl dicarboxylic acid
(1,1'-biphenyl)-4,4'-dicarboxylic acid
[1,4'-dicarboxylic acid
nsc-60016
p,p'-diphenic acid
4,4'-dicarboxybiphenyl
4,4'-bibenzoic acid
nsc60016
4,4'-diphenic acid
787-70-2
wln: qvr dr dvq
4,4'-biphenyldicarboxylic acid
usaf do-69
biphenyl-4,4'-dicarboxylic acid, 97%
OPREA1_519768
STK012281
4,4'-diphenyldicarboxylic acid
b1191 ,
4,4'-dibenzoic acid
4-(4-carboxyphenyl)benzoic acid
FT-0656177
AKOS000119440
A840924
A839493
84787-70-2
[1,1'-biphenyl]-4,4'-dicarboxylic acid
biphenyl-4,4-dicarboxylic acid
4,4'-bisbenzoic acid
4-09-00-03563 (beilstein handbook reference)
FT-0632956
F3096-1199
SCHEMBL69873
biphenyl-4.4'-dicarboxylic acid
DTXSID7061140
SY015816
biphenyl-4,4 inverted exclamation mark -dicarboxylic acid
mfcd00002554
W-104270
STR04514
PS-7561
AC-23047
CHEMBL3593502
biphenyl-4,4'-dicarboxylic acid, vetec(tm) reagent grade, 97%
biphenyl-4,4`-dicarboxylic acid
CS-W014653
biphenyl-4,4-dicarboxylicacid
fema 3005
YSWG150
Q2662185
CK2208
EN300-17943
5D8ABY24N2
sandalwood oil from santalum album l.
HY-W013937
Z57127884
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1235354Antifungal activity against Cochliobolus lunatus strain MUCL 38696 at 100 uM by growth based assay2015Bioorganic & medicinal chemistry, Aug-01, Volume: 23, Issue:15
Benzoic acid derivatives with improved antifungal activity: Design, synthesis, structure-activity relationship (SAR) and CYP53 docking studies.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (9.09)29.6817
2010's8 (72.73)24.3611
2020's2 (18.18)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 40.28

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index40.28 (24.57)
Research Supply Index2.48 (2.92)
Research Growth Index5.56 (4.65)
Search Engine Demand Index50.49 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (40.28)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]